glp-1 news insurers Costly Drugs are Rarely Covered for Weight Loss by Marketplace Plans As insurers struggle with GLP-1
Description
They mimic the action of the naturally occurring hormone GLP-1, which is involved in regulating blood sugar levels
Wegovy (semaglutide for weight loss) is a separate drug with separate coverage rules, even though the active ingredient is identical
Estimular a secreo de insulina , ajudando no controle da glicemia
Exenatide, the first GLP-1RA approved in 2005, demonstrated clinical efficacy but its low homology with human GLP-1 and gastrointestinal side effects restricted widespread use (Muttenthaler et al., 2021)
